Lucy Scientific Discovery Inc (LSDI)
0.8902
+0.06
(+7.01%)
USD |
NASDAQ |
May 01, 16:00
0.8902
0.00 (0.00%)
After-Hours: 20:00
Lucy Scientific Discovery SG&A Expense (Quarterly): 0.8683M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.8683M |
September 30, 2023 | 1.510M |
June 30, 2023 | 2.103M |
March 31, 2023 | 2.388M |
December 31, 2022 | 0.182M |
Date | Value |
---|---|
September 30, 2022 | 0.8286M |
June 30, 2022 | 0.8885M |
March 31, 2022 | 1.103M |
December 31, 2021 | 0.7635M |
September 30, 2021 | 0.7145M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.182M
Minimum
Dec 2022
2.388M
Maximum
Mar 2023
1.135M
Average
0.8784M
Median
SG&A Expense (Quarterly) Benchmarks
Rimrock Gold Corp | 0.1187M |
InMed Pharmaceuticals Inc | 1.364M |
Venus Concept Inc | 18.03M |
Juva Life Inc | 1.414M |
CEN Biotech Inc | 0.478M |